---
schema_version: "secwatch.filing_event.v1"
accession: "0000856982-24-000065"
form_type: "8-K"
ticker: "MMSI"
cik: "0000856982"
company_name: "MERIT MEDICAL SYSTEMS INC"
filed_at: "2024-07-01T23:59:59+00:00"
generated_at: "2026-06-01T00:20:54.131034+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Merit Medical acquires EndoGastric Solutions' EsophyX Z+ device for $105M; updates 2024 guidance

## Summary
- Asset purchase of EsophyX Z+ device for $105M cash, financed via credit facility draws.
- Projected to add ~$30M annualized revenue, leveraging existing GI endoscopy commercial footprint.
- Modestly dilutive to full-year 2024 non-GAAP profitability but expected accretive in first full year post-closing.
- Reaffirmed standalone 2024 guidance; updated outlook to include partial-year impact; details on Aug 1 Q2 call.

## SEC filing metadata
- accession: 0000856982-24-000065
- form_type: 8-K
- ticker: MMSI
- cik: 0000856982
- company_name: MERIT MEDICAL SYSTEMS INC
- filed_at: 2024-07-01T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 1.01, 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/856982/000085698224000065/0000856982-24-000065-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/856982/000085698224000065/mmsi-20240701x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000856982-24-000065
- JSON: https://secwatch.observer/filing/0000856982-24-000065.json
- Plain text: https://secwatch.observer/filing/0000856982-24-000065.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.